Skip to main content
Log in

Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Maghoub A, Idle JR, Dring LG, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet II: 584–586

    Google Scholar 

  2. Eichelbaum M, Spannbrucker N, Steinecke B, Dengler HJ (1979) Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol 16: 183–187

    Google Scholar 

  3. Gonzales FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Mayer UA (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 33: 442–446

    Google Scholar 

  4. Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T, Dayer P (1986) Molecular mechanisms of two common polymorphisms of drug oxidation. Evidence for functional changes in cytochrome P-450 isozymes catalyzing bufuralol and mephenytoin oxidation. Xenobiotica 16: 449–464

    Google Scholar 

  5. Price Evans DA (1986) In: Kalow W, Goedde HW, Agarwal DP (eds) Ethnic differences in reactions to drugs and xenobiotics. New York, Liss, 491–526 (Progress in clinical and biological research, 214)

    Google Scholar 

  6. Schmid B, Bircher J, Preisig R, Kupfer A (1985) Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquine hydroxylation. Clin Pharmacol Ther 38: 618–624

    Google Scholar 

  7. Von Bahr C, Guengerich FP, Movin G, Nordin C (1985) The use of human liver banks in pharmacogenetic research. In: Dahl SG, Gram LF (eds) Clinical Pharmacology in Psychiatry. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  8. Baumann P, Jonzier-Perey M (1988) GC and GC-Ms procedures for simultaneous phenotyping with dextromethrophan and mephenytoin. Clin Chim Acta 171: 211–222

    Google Scholar 

  9. Kilts CD, Patrick KS, Breese GR, Mailman RB (1982) Simultaneous determination of thioridazine and its S-oxidized and N-demthylated metabolites using high-performance liquid chromatography on radially compressed silica. J Chromatogr 231: 377–391

    Google Scholar 

  10. Skoda RC, Gonzales FJ, Demierre A, Meyer UA (1988) Two mutant alleles of the human cytochrome P-450dbl (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc Natl Acad Sci USA 85: 5240–5243

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by Swiss National Science Foundation (32-8651.85/2)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer, J.W., Woggon, B., Baumann, P. et al. Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type. Eur J Clin Pharmacol 39, 613–614 (1990). https://doi.org/10.1007/BF00316110

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00316110

Key words

Navigation